Graham C. Parry
0000-0002-3009-4947
Publication & Citation Trends
Publications
95 total
SAR443809: a selective inhibitor of the complement alternative pathway, targeting complement factor Bb OA
Cited by 7
Semantic Scholar
Anti-C1s humanized monoclonal antibody SAR445088: A classical pathway complement inhibitor specific for the active form of C1s. OA
Cited by 10
Semantic Scholar
LATE BREAKING POSTERS THE DETRIMENTAL SYNERGISTIC EFFECT OF HYPOXIA AND COMPLEMENT MASP1 IN THE ATHEROSCLEROSIS-RELATED DISEASES, ON ENDOTHELIAL CELL MODEL.
Cited by 0
Semantic Scholar
Effect of a C1s Inhibitor on the Efficacy of Anti-Capsular Antibodies against Neisseria meningitidis and Streptococcus pneumoniae OA
Cited by 8
Semantic Scholar
Inhibition of complement C1s improves severe hemolytic anemia in cold agglutinin disease: a first-in-human trial. OA
Cited by 99
Semantic Scholar
Specific inhibition of the classical complement pathway prevents C3 deposition along the dermal-epidermal junction in bullous pemphigoid. OA
Cited by 33
Semantic Scholar
C1s Inhibition by BIVV009 (Sutimlimab) Prevents Complement-Enhanced Activation of Autoimmune Human B Cells In Vitro OA
Cited by 28
Semantic Scholar
Anti‐C1s monoclonal antibody BIVV009 in late antibody‐mediated kidney allograft rejection—results from a first‐in‐patient phase 1 trial OA
Cited by 75
Semantic Scholar
Research Topics
Protease and Inhibitor Mechanisms
(22)
Blood Coagulation and Thrombosis Mechanisms
(20)
Cell Adhesion Molecules Research
(16)
Complement system in diseases
(16)
Blood groups and transfusion
(12)
Affiliations
Scripps Research Institute
University of London
University of Colorado Hospital
The University of Texas MD Anderson Cancer Center
Inserm